HIF-1α-induced β-catenin activation prevents prion-mediated neurotoxicity

Jeong,Jae-Kyo; Park,Sang-Youel

doi:10.3892/ijmm.2013.1457

HIF-1α-induced β-catenin activation prevents prion-mediated neurotoxicity

Authors:
- Jae-Kyo Jeong
- Sang-Youel Park
View Affiliations

Affiliations: Bio-Safety Research Institute, College of Veterinary Medicine, Chonbuk National University, Jeonju, Jeonbuk 561-756, Republic of Korea
Published online on: July 26, 2013 https://doi.org/10.3892/ijmm.2013.1457
Pages: 931-937

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous studies have shown that hypoxic preconditioning attenuates prion-mediated neurotoxicity by upregulating hypoxia inducible factor-1α (HIF-1α). However, the mechanisms behind the HIF-1α-mediated neuroprotective effects in neurodegenerative disorders, including prion diseases, are unclear. It is well known that HIF-1α regulates Wnt/β‑catenin signaling and that β-catenin protects neurons against misfolded protein-mediated disorders, including Alzheimer's and Parkinson's disease by preventing mitochondrial malfunction. Thus, we hypothesized that the mechanisms responsible for HIF-1α-mediated neuroprotection are associated with β-catenin activation induced by the regulation of mitochondrial function. We used the SH-SY5Y human neuroblastoma cell line and treated the cells with melatonin and then exposed them to the prion protein, PrP, or the β-catenin inhibitor, ICG-001. TUNEL assay was used to measure apoptosis. β-catenin expression measured by western blot analysis. The results revealed that HIF-1α prevented prion protein (PrP) (106‑126)-induced neurotoxicity by activating β-catenin. Moreover, HIF-1α-induced β-catenin activation prevented the PrP (106‑126)-induced mitochondrial damage under hypoxic conditions, as evidenced by the higher mitochondrial transmembrane potential values in the cells exposed to hypoxic conditions. These results indicate that the regulation of β-catenin activation by HIF-1α may be a therapeutic strategy for prion-mediated disorders.

View Figures

View References

1	Prusiner SB: Prions. Proc Natl Acad Sci USA. 95:13363–13383. 1998. View Article : Google Scholar : PubMed/NCBI
2	Wickner RB: Prion diseases: Infectivity versus toxicity. Nature. 470:470–471. 2011. View Article : Google Scholar : PubMed/NCBI
3	Eghiaian F, Grosclaude J, Lesceu S, et al: Insight into the PrPC→PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants. Proc Natl Acad Sci USA. 101:10254–10259. 2004.
4	Turnbaugh JA, Unterberger U, Saá P, et al: The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc). J Neurosci. 32:8817–8830. 2012. View Article : Google Scholar : PubMed/NCBI
5	Sim VL and Caughey B: Ultrastructures and strain comparison of under-glycosylated scrapie prion fibrils. Neurobiol Aging. 30:2031–2042. 2009. View Article : Google Scholar : PubMed/NCBI
6	Jeong JK, Moon MH, Bae BC, et al: Autophagy induced by resveratrol prevents human prion protein-mediated neurotoxicity. Neurosci Res. 73:99–105. 2012. View Article : Google Scholar : PubMed/NCBI
7	Jeong JK, Moon MH, Lee YJ, Seol JW and Park SY: Autophagy induced by the class III histone deacetylase Sirt1 prevents prion peptide neurotoxicity. Neurobiol Aging. 34:146–156. 2013. View Article : Google Scholar : PubMed/NCBI
8	Aiken JM, Williamson JL and Marsh RF: Evidence of mitochondrial involvement in scrapie infection. J Virol. 63:1686–1694. 1989.PubMed/NCBI
9	Quintanilla RA, Dolan PJ, Jin YN and Johnson GV: Truncated tau and Aβ cooperatively impair mitochondria in primary neurons. Neurobiol Aging. 33:619.e25–35. 2012.
10	Freixes M, Rodriguez A, Dalfo E and Ferrer I: Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease. Neurobiol Aging. 27:1807–1815. 2006. View Article : Google Scholar : PubMed/NCBI
11	Jeong JK, Moon MH, Park YG, et al: Gingerol-induced hypoxia-inducible factor 1 alpha inhibits human prion peptide-mediated neurotoxicity. Phytother Res. 27:1185–1192. 2013. View Article : Google Scholar : PubMed/NCBI
12	Xie L, Johnson RS and Freeman RS: Inhibition of NGF deprivation-induced death by low oxygen involves suppression of BIMEL and activation of HIF-1. J Cell Biol. 168:911–920. 2005. View Article : Google Scholar : PubMed/NCBI
13	Strey CW, Gestrich J, Beckhaus T, et al: Hypoxia and reoxygenation of primary human hepatocytes induce proteome changes of glucose metabolism, oxidative protection and peroxisomal function. Int J Mol Med. 26:577–584. 2010. View Article : Google Scholar
14	Selvendiran K, Bratasz A, Kuppusamy ML, Tazi MF, Rivera BK and Kuppusamy P: Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3. Int J Cancer. 125:2198–2204. 2009. View Article : Google Scholar : PubMed/NCBI
15	Gardner LB and Corn PG: Hypoxic regulation of mRNA expression. Cell Cycle. 7:1916–1924. 2008. View Article : Google Scholar
16	Malik A, Korol A, Weber M, Hankeln T, Avivi A and Band M: Transcriptome analysis of the spalax hypoxia survival response includes suppression of apoptosis and tight control of angiogenesis. BMC Genomics. 13:6152012. View Article : Google Scholar
17	Ryan HE, Lo J and Johnson RS: HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17:3005–3015. 1998. View Article : Google Scholar : PubMed/NCBI
18	Lee SH, Koo KH, Park JW, et al: HIF-1 is induced via EGFR activation and mediates resistance to anoikis-like cell death under lipid rafts/caveolae-disrupting stress. Carcinogenesis. 30:1997–2004. 2009. View Article : Google Scholar : PubMed/NCBI
19	Adams JM, Difazio LT, Rolandelli RH, et al: HIF-1: a key mediator in hypoxia. Acta Physiol Hung. 96:19–28. 2009. View Article : Google Scholar : PubMed/NCBI
20	Koh MY, Spivak-Kroizman TR and Powis G: HIF-1alpha and cancer therapy. Recent Results Cancer Res. 180:15–34. 2010. View Article : Google Scholar : PubMed/NCBI
21	Ke Q and Costa M: Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol. 70:1469–1480. 2006. View Article : Google Scholar : PubMed/NCBI
22	Jeong JK, Seo JS, Moon MH, Lee YJ, Seol JW and Park SY: Hypoxia-inducible factor-1α regulates prion protein expression to protect against neuron cell damage. Neurobiol Aging. 33:1006.e1–10. 2012.
23	Singh N, Sharma G and Mishra V: Hypoxia inducible factor-1: its potential role in cerebral ischemia. Cell Mol Neurobiol. 32:491–507. 2012. View Article : Google Scholar : PubMed/NCBI
24	Seo JS, Seol JW, Moon MH, Jeong JK, Lee YJ and Park SY: Hypoxia protects neuronal cells from human prion protein fragment-induced apoptosis. J Neurochem. 112:715–722. 2010. View Article : Google Scholar : PubMed/NCBI
25	Zhang Q, Qian Z, Pan L, Li H and Zhu H: Hypoxia-inducible factor 1 mediates the anti-apoptosis of berberine in neurons during hypoxia/ischemia. Acta Physiol Hung. 99:311–323. 2012. View Article : Google Scholar : PubMed/NCBI
26	Cunningham LA, Candelario K and Li L: Roles for HIF-1α in neural stem cell function and the regenerative response to stroke. Behav Brain Res. 227:410–417. 2012.
27	Lehwald N, Tao GZ, Jang KY, et al: β-Catenin regulates hepatic mitochondrial function and energy balance in mice. Gastroenterology. 143:754–764. 2012.
28	Flaherty MP, Kamerzell TJ and Dawn B: Wnt signaling and cardiac differentiation. Prog Mol Biol Transl Sci. 111:153–174. 2012. View Article : Google Scholar
29	Wiedau-Pazos M, Wong E, Solomon E, Alarcon M and Geschwind DH: Wnt-pathway activation during the early stage of neurodegeneration in FTDP-17 mice. Neurobiol Aging. 30:14–21. 2009. View Article : Google Scholar : PubMed/NCBI
30	Meyers J, Hu L, Moses A, Kaboli K, Papandrea A and Raymond P: β-catenin/Wnt signaling controls progenitor fate in the developing and regenerating zebrafish retina. Neural Dev. 7:302012.
31	Mazumdar J, O’Brien WT, Johnson RS, et al: O₂ regulates stem cells through Wnt/β-catenin signalling. Nat Cell Biol. 12:1007–1013. 2010.
32	Wei L, Sun C, Lei M, et al: Activation of Wnt/β-catenin pathway by exogenous Wnt1 protects SH-SY5Y cells against 6-hydroxydopamine toxicity. J Mol Neurosci. 49:105–115. 2013.
33	Liu S, Yeh TH, Singh VP, et al: β-Catenin is essential for ethanol metabolism and protection against alcohol-mediated liver steatosis in mice. Hepatology. 55:931–940. 2012.
34	Mitani T, Harada N, Nakano Y, Inui H and Yamaji R: Coordinated action of hypoxia-inducible factor-1α and β-catenin in androgen receptor signaling. J Biol Chem. 287:33594–33606. 2012.
35	Jeong JK, Moon MH, Seo JS, Seol JW, Park SY and Lee YJ: Hypoxia inducing factor-1alpha regulates tumor necrosis factor-related apoptosis-inducing ligand sensitivity in tumor cells exposed to hypoxia. Biochem Biophys Res Commun. 399:379–383. 2010. View Article : Google Scholar
36	L’Episcopo F, Tirolo C, Testa N, et al: Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson’s disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for neuroprotection and repair. J Neurosci. 32:2062–2085. 2012.PubMed/NCBI
37	Liang J, Liu L and Xing D: Photobiomodulation by low-power laser irradiation attenuates Aβ-induced cell apoptosis through the Akt/GSK3β/β-catenin pathway. Free Radic Biol Med. 53:1459–1467. 2012.
38	Hota KB, Hota SK, Srivastava RB and Singh SB: Neuroglobin regulates hypoxic response of neuronal cells through Hif-1α- and Nrf2-mediated mechanism. J Cereb Blood Flow Metab. 32:1046–1060. 2012.PubMed/NCBI